191 related articles for article (PubMed ID: 31077805)
1. The West coast regional safety pharmacology society meeting update: Filling translational gaps in safety assessment.
Abi-Gerges N; McMahon C; Vargas H; Sager P; Chui R; Stevens D; Davila J; Schaub JR; Wu JC; Del Rio C; Mathes C; Miller PE; Burns-Naas LA; Ghetti A
J Pharmacol Toxicol Methods; 2019; 98():106582. PubMed ID: 31077805
[TBL] [Abstract][Full Text] [Related]
2. The northeast regional SPS meeting update: Safety pharmacology innovations and applications.
Pannirselvam M; Brabham T; Botchway AW; Hodges DB; Traebert M; Pugsley MK
J Pharmacol Toxicol Methods; 2017; 85():82-86. PubMed ID: 27913272
[TBL] [Abstract][Full Text] [Related]
3. Drug safety Africa: An overview of safety pharmacology & toxicology in South Africa.
Guth BD; Grobler AF; Frazier KS; Greiter-Wilke A; Herzyk D; Hough TA; Khan AA; Markert M; Smith JD; Svenson KL; Wells S; Pugsley MK
J Pharmacol Toxicol Methods; 2019; 98():106579. PubMed ID: 31085319
[TBL] [Abstract][Full Text] [Related]
4. Methodological innovations expand the safety pharmacology horizon.
Pugsley MK; Curtis MJ
J Pharmacol Toxicol Methods; 2012 Sep; 66(2):59-62. PubMed ID: 22617368
[TBL] [Abstract][Full Text] [Related]
5. Safety pharmacology methods and models in an evolving regulatory environment.
Pugsley MK; de Korte T; Authier S; Huang H; Accardi MV; Curtis MJ
J Pharmacol Toxicol Methods; 2017 Sep; 87():1-6. PubMed ID: 28461240
[TBL] [Abstract][Full Text] [Related]
6. An overview of the safety pharmacology society strategic plan.
Pugsley MK; Authier S; Koerner JE; Redfern WS; Markgraf CG; Brabham T; Correll K; Soloviev MV; Botchway A; Engwall M; Traebert M; Valentin JP; Mow TJ; Greiter-Wilke A; Leishman DJ; Vargas HM
J Pharmacol Toxicol Methods; 2018; 93():35-45. PubMed ID: 29330132
[TBL] [Abstract][Full Text] [Related]
7. Response of safety pharmacologists to challenges arising from the rapidly evolving changes in the pharmaceutical industry.
Bass AS; Pugsley MK; Sannajust F; Yoshinaga T; Valentin JP
J Pharmacol Toxicol Methods; 2019; 98():106593. PubMed ID: 31158459
[TBL] [Abstract][Full Text] [Related]
8. Benchmarking safety pharmacology regulatory packages and best practice.
Lindgren S; Bass AS; Briscoe R; Bruse K; Friedrichs GS; Kallman MJ; Markgraf C; Patmore L; Pugsley MK
J Pharmacol Toxicol Methods; 2008; 58(2):99-109. PubMed ID: 18692579
[TBL] [Abstract][Full Text] [Related]
9. Safety pharmacology in 2010 and beyond: survey of significant events of the past 10 years and a roadmap to the immediate-, intermediate- and long-term future in recognition of the tenth anniversary of the Safety Pharmacology Society.
Bass AS; Vargas HM; Valentin JP; Kinter LB; Hammond T; Wallis R; Siegl PK; Yamamoto K
J Pharmacol Toxicol Methods; 2011; 64(1):7-15. PubMed ID: 21689769
[TBL] [Abstract][Full Text] [Related]
10. Innovation in safety pharmacology testing.
Pugsley MK; Towart R; Authier S; Gallacher DJ; Curtis MJ
J Pharmacol Toxicol Methods; 2011; 64(1):1-6. PubMed ID: 21640842
[TBL] [Abstract][Full Text] [Related]
11. Safety pharmacology 2023 and implementation of the ICH E14/S7B Q&A guidance document.
Pugsley MK; Koshman YE; Foley CM; Winters BR; Authier S; Curtis MJ
J Pharmacol Toxicol Methods; 2023; 123():107300. PubMed ID: 37524151
[TBL] [Abstract][Full Text] [Related]
12. How do the top 12 pharmaceutical companies operate safety pharmacology?
Ewart L; Gallacher DJ; Gintant G; Guillon JM; Leishman D; Levesque P; McMahon N; Mylecraine L; Sanders M; Suter W; Wallis R; Valentin JP
J Pharmacol Toxicol Methods; 2012 Sep; 66(2):66-70. PubMed ID: 22510338
[TBL] [Abstract][Full Text] [Related]
13. 2011 Annual Meeting of the Safety Pharmacology Society: an overview.
Cavero I
Expert Opin Drug Saf; 2012 Mar; 11(2):341-53. PubMed ID: 22339583
[TBL] [Abstract][Full Text] [Related]
14. Methodology used in safety pharmacology: appraisal of the state-of-the-art, the regulatory issues and new directions.
Pugsley MK
J Pharmacol Toxicol Methods; 2005; 52(1):1-5. PubMed ID: 15982903
[TBL] [Abstract][Full Text] [Related]
15. A Historical View and Vision into the Future of the Field of Safety Pharmacology.
Bass AS; Hombo T; Kasai C; Kinter LB; Valentin JP
Handb Exp Pharmacol; 2015; 229():3-45. PubMed ID: 26091634
[TBL] [Abstract][Full Text] [Related]
16. Methods in safety pharmacology in focus.
Pugsley MK; Gallacher DJ; Towart R; Authier S; Curtis MJ
J Pharmacol Toxicol Methods; 2008; 58(2):69-71. PubMed ID: 18707009
[TBL] [Abstract][Full Text] [Related]
17. Safety pharmacology methods and regulatory considerations evolve together.
Pugsley MK; Harter ML; de Korte T; Connaughton C; Authier S; Curtis MJ
J Pharmacol Toxicol Methods; 2018; 93():1-6. PubMed ID: 29936032
[No Abstract] [Full Text] [Related]
18. Trends in safety pharmacology: posters presented at the annual meetings of the Safety Pharmacology Society 2001-2010.
Redfern WS; Valentin JP
J Pharmacol Toxicol Methods; 2011; 64(1):102-10. PubMed ID: 21635957
[TBL] [Abstract][Full Text] [Related]
19. An Industry Survey With Focus on Cardiovascular Safety Pharmacology Study Design and Data Interpretation.
Authier S; Abernathy MM; Correll K; Chui RW; Dalton J; Foley CM; Friedrichs GS; Koerner JE; Kallman MJ; Pannirselvam M; Redfern WS; Urmaliya V; Valentin JP; Wisialowski T; Zabka TS; Pugsley MK
Int J Toxicol; 2020; 39(4):274-293. PubMed ID: 32406289
[TBL] [Abstract][Full Text] [Related]
20. Introduction to the theme "Precision medicine and prediction in pharmacology".
Insel PA; Amara SG; Blaschke TF
Annu Rev Pharmacol Toxicol; 2015; 55():11-4. PubMed ID: 25562643
[No Abstract] [Full Text] [Related]
[Next] [New Search]
